Treatment of primary melanoma of the lung monitored by 5-S-cysteinyldopa levels.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19324166.
- Also identified by DOI 10.1016/j.athoracsur.2008.08.052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malignant melanoma originating outside the skin is very rare, whereas primary malignant melanoma of the lung is extremely rare. 5-S-Cysteinyldopa (5-S-CD), a melanin metabolite, has been reported to be a prognostic marker for cutaneous malignant melanoma. This is the first report in the English language literature dealing with primary malignant melanoma of the lung using serum 5-S-Cysteinyldopa levels to monitor the effects of surgery and chemotherapy.
Medical subject headings
- Cysteinyldopa
- Lung Neoplasms
- Melanoma